oropharynx squamous cell carcinoma
Showing 1 - 16 of 16
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Circulating Biomarkers in Oropharyngeal Cancers
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
-
Orebro, SwedenAnna Oldaeus Almerén
Jun 13, 2023
Oropharynx Squamous Cell Carcinoma Trial (Blood sample)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- Blood sample
- (no location specified)
Jan 12, 2023
Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Head Neck Cancer, Dysphagia, Oropharyngeal Dysphagia Trial in Chicago, Evanston (Respiratory-Swallow Phase Training, Swallow
Recruiting
- Head and Neck Cancer
- +3 more
- Respiratory-Swallow Phase Training
- Swallow Practice
-
Chicago, Illinois
- +1 more
Dec 13, 2022
Oropharynx Squamous Cell Carcinoma Trial (HPV16 Ct-DNA dosing)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- HPV16 Ct-DNA dosing
- (no location specified)
Oct 13, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Oral and Throat Cancers Using OralViome Cancer Testing System
Recruiting
- Oral Squamous Cell Carcinoma
- +2 more
- OralViome Cancer Testing System
-
New York, New YorkNYMC
Aug 5, 2022
Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,
Recruiting
- Head Neck Cancer
- +5 more
- Pembrolizumab
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Aug 8, 2022
Oropharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Bordeaux, Nice (Mandibular Reconstruction (MR)
Recruiting
- Oropharynx Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP).
- Conventional Mandibular Reconstruction (MR without PVP)
-
Bordeaux, France
- +1 more
May 11, 2022
Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels
Recruiting
- Oropharynx Squamous Cell Carcinoma
- +3 more
- IO102
- IO103
-
Brussels, BelgiumCliniques Universitaires Saint-Luc
May 6, 2022
Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Oropharynx Squamous Cell Carcinoma
- Nivolumab Injection
- Radiotherapy (RT)
-
Atlanta, Georgia
- +2 more
Mar 24, 2022
Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- +3 more
-
Rochester, Minnesota
- +1 more
Oct 5, 2021
Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,
Recruiting
- Oropharynx Cancer
- +18 more
- Intensity-Modulated Radiation Therapy (IMRT)
- +3 more
-
Aarhus, Denmark
- +2 more
Sep 28, 2021
QUantitative Assessment of Swallowing After Radiation (QUASAR)
Recruiting
- Head and Neck Cancer
- +4 more
- Radiation Therapy
- +3 more
-
La Jolla, California
- +1 more
Feb 4, 2021
(IMPT) or TransOral Robotic Surgery for Treatment of Low-Risk
Unknown status
- Cancer of the Mouth
- Oropharynx Squamous Cell Carcinoma
- Symptom Questionnaires
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 21, 2019